|
| |
National Mastectomy and Breast Reconstruction Audit |
| |
Name |
Position |
Date Agreed |
Date Completed Date |
|
| |
Mr Kieran Horgan |
NSSG Chair |
Apr 2007 |
Mar 2009 |
 |
| |
Mr Rob Webster |
YCN Board Chair |
Aug 2009 |
- |
 |
| |
|
| |
The audit will:
- describe provision of and access to breast reconstruction in England and Wales
- evaluate current clinical practice in mastectomy and breast reconstruction
- measure outcomes following mastectomy with or without reconstruction
- assess the quality of information provided to women undergoing mastectomy
and their satisfaction with the reconstructive choices made.
|
| |
The Breast Cancer Clinical Outcome Measures (BCCOM) Project |
| |
Name |
Position |
Date Agreed |
Date Completed Date |
|
| |
Mr Kieran Horgan |
NSSG Chair |
Oct 2009 |
- |
 |
| |
Mr Rob Webster |
YCN Board Chair |
Aug 2009 |
- |
 |
| |
|
| |
- To audit across the UK the treatment of symptomatic breast cancer
- To compare management with published national standards and targets
- To measure against treatment’ hypotheses/gold standards
- To inform the setting of future standards
- To obtain complete and accurate outcome measures including survival
|
| |
Audit of Timeliness of Communications for Breast Cancer in the YCN |
| |
Name |
Position |
Date Agreed |
Date Completed Date |
|
| |
Mr Ben Mancey-Jones |
NSSG Chair |
Jan 2010 |
Apr 2010 |
 |
| |
Mr Rob Webster |
YCN Board Chair |
Sep 2010 |
- |
 |
| |
|
| |
- To review the timeliness of patients being informed their diagnosis of breast cancer in order to determine any possible variation across the Network.
- To review the % of all referrals receiving radiology results on the day of their first visit to clinic in order to determine any possible variation across the Network.
- To review the timeliness of deciding the adjuvant treatment plan following surgery in order to determine any possible variation across the Network.
- To provide a baseline position against which future audits can be compared.
- To provide evidence for the current guidelines and introduce new ones agreed by the Group in the light of current practice and evidence from the literature.
- The results will be presented by each MDT to the YCN Breast Network Site Specific Group which will suggest possible changes in practice.
|
| |
Prospective Audit of Family History Referrals to each Trust in the YCN |
| |
Name |
Position |
Date Agreed |
Date Completed Date |
|
| |
Mr Ben Mancey-Jones |
NSSG Chair |
Apr 2010 |
Oct 2010 |
 |
| |
Mr Rob Webster |
YCN Board Chair |
Sep 2010 |
- |
 |
| |
|
| |
- To provide the best possible estimate of patient numbers in the YCN area currently undergoing family history breast screening, together with the rate of new referrals.
- To support development of a YCN pathway and to assist commissioners and providers in assessing impact on services.
|
| |
Audit of availability of key tumour data at 1st therapeutic MDT |
| |
Name |
Position |
Date Agreed |
Date Completed Date |
|
| |
Mr Ben Mancey-Jones |
NSSG Chair |
Oct 2010 |
Mar 2011 |
 |
| |
Mr Rob Webster |
YCN Board Chair |
Jan 2011 |
- |
 |
| |
|
| |
- To determine the proportion of all breast cancer patients that have 5 key tumour data items available at the time of first therapeutic MDT discussion.
Key items:
- Tumour size
- Tumour grade
- Nodal status
- ER status
- HER2 status
- To fully investigate those patients with missing key tumour data at the time of first therapeutic MDT to understand reasons why and identify improvements that could be made.
|